| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |